• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RHAMM是一种调节ras信号传导的透明质酸结合蛋白,其过表达与丝裂原活化蛋白激酶的过表达相关,并且是乳腺癌进展中的一个重要参数。

The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.

作者信息

Wang C, Thor A D, Moore D H, Zhao Y, Kerschmann R, Stern R, Watson P H, Turley E A

机构信息

Department of Anatomy and Cell Biology, University of Toronto, and The Hospital for Sick Children, Ontario, Canada.

出版信息

Clin Cancer Res. 1998 Mar;4(3):567-76.

PMID:9533523
Abstract

RHAMM is an oncogene that regulates signaling through ras and controls mitogen-activated protein kinase [extracellular signal-regulated protein kinase (ERK)] expression in embryonic murine fibroblasts. ERK is a dual-specificity kinase that controls expression of proteins relevant to tumorigenesis, proliferation, and motility. To assess whether RHAMM and ERK are involved in human breast tumor progression, we examined RHAMM, ras, and ERK expression in two cohorts of breast cancer patients using reverse transcription-PCR and immunocytochemistry. We show that overexpression of RHAMM in primary tumors of two patient cohorts was significantly prognostic of poor outcome in breast cancer progression. Furthermore, RHAMM overexpression occurred within subsets of tumor cells in the primary tumor, and this staining pattern was associated with lymph node metastases. The metastases exhibited a significantly higher level of staining for RHAMM than did the primary tumor. RHAMM expression strongly correlated with overexpression of both ras and ERK, although overexpression of either of these two signaling molecules was not by itself a prognostic indicator. These results identify a new parameter that is involved in lymph node metastasis of primary breast cancers and suggest that quantification of RHAMM overexpression may be a useful prognostic indicator for breast carcinoma progression.

摘要

透明质酸介导运动受体(RHAMM)是一种癌基因,它通过Ras调节信号传导,并控制胚胎小鼠成纤维细胞中丝裂原活化蛋白激酶[细胞外信号调节蛋白激酶(ERK)]的表达。ERK是一种双特异性激酶,可控制与肿瘤发生、增殖和运动相关的蛋白质表达。为了评估RHAMM和ERK是否参与人类乳腺肿瘤进展,我们使用逆转录聚合酶链反应(RT-PCR)和免疫细胞化学方法检测了两组乳腺癌患者中RHAMM、Ras和ERK的表达。我们发现,在两组患者的原发性肿瘤中,RHAMM的过表达是乳腺癌进展不良预后的显著指标。此外,RHAMM过表达发生在原发性肿瘤的部分肿瘤细胞中,这种染色模式与淋巴结转移相关。转移灶中RHAMM的染色水平明显高于原发性肿瘤。RHAMM表达与Ras和ERK的过表达密切相关,尽管这两种信号分子单独过表达均不是预后指标。这些结果确定了一个参与原发性乳腺癌淋巴结转移的新参数,并表明RHAMM过表达的定量分析可能是乳腺癌进展的一个有用的预后指标。

相似文献

1
The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.RHAMM是一种调节ras信号传导的透明质酸结合蛋白,其过表达与丝裂原活化蛋白激酶的过表达相关,并且是乳腺癌进展中的一个重要参数。
Clin Cancer Res. 1998 Mar;4(3):567-76.
2
Expression of hyaluronan receptors CD44 and RHAMM in stomach cancers: relevance with tumor progression.透明质酸受体CD44和RHAMM在胃癌中的表达:与肿瘤进展的相关性
Int J Oncol. 2000 Nov;17(5):927-32.
3
High expression of focal adhesion kinase (p125FAK) in node-negative breast cancer is related to overexpression of HER-2/neu and activated Akt kinase but does not predict outcome.粘着斑激酶(p125FAK)在淋巴结阴性乳腺癌中的高表达与HER-2/neu的过表达及Akt激酶的激活相关,但不能预测预后。
Breast Cancer Res. 2005;7(2):R194-203. doi: 10.1186/bcr977. Epub 2005 Jan 7.
4
Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.与肿瘤相关脂肪酸合酶依赖性乳腺癌细胞增殖和存活相关的新型信号分子:外源性膳食脂肪酸、p53-p21WAF1/CIP1、ERK1/2 MAPK、p27KIP1、BRCA1和NF-κB的作用
Int J Oncol. 2004 Mar;24(3):591-608.
5
Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.Raf-1激酶抑制蛋白表达的降低与乳腺癌转移相关。
Clin Cancer Res. 2005 Oct 15;11(20):7392-7. doi: 10.1158/1078-0432.CCR-05-0283.
6
RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.RHAMM、p21联合表型可识别微卫星高度不稳定且预后极差的结直肠癌。
Clin Cancer Res. 2008 Jun 15;14(12):3798-806. doi: 10.1158/1078-0432.CCR-07-5103.
7
Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.早期乳腺癌患者中p27蛋白免疫反应性降低与HER-2/neu过表达相关,且与淋巴结阴性患者接受一个疗程围手术期化疗的获益相关:国际乳腺癌研究组V期试验结果
Cancer. 2003 Apr 1;97(7):1591-600. doi: 10.1002/cncr.11224.
8
p38 kinase is a key signaling molecule for H-Ras-induced cell motility and invasive phenotype in human breast epithelial cells.p38激酶是人类乳腺上皮细胞中H-Ras诱导的细胞运动性和侵袭表型的关键信号分子。
Cancer Res. 2003 Sep 1;63(17):5454-61.
9
Activated mitogen-activated protein kinase expression during human breast tumorigenesis and breast cancer progression.人乳腺肿瘤发生和乳腺癌进展过程中活化的丝裂原活化蛋白激酶表达
Clin Cancer Res. 2002 Jun;8(6):1747-53.
10
Mitogen-activated protein kinase phosphatase-1 in human breast cancer independently predicts prognosis and is repressed by doxorubicin.丝裂原活化蛋白激酶磷酸酶-1在人类乳腺癌中可独立预测预后,且受阿霉素抑制。
Clin Cancer Res. 2009 May 15;15(10):3530-9. doi: 10.1158/1078-0432.CCR-08-2070. Epub 2009 May 5.

引用本文的文献

1
Targeting RHAMM in Cancer: Crosstalk with Non-Coding RNAs and Emerging Therapeutic Strategies Including Peptides, Oligomers, Antibodies, and Vaccines.癌症中靶向透明质酸介导的运动受体(RHAMM):与非编码RNA的相互作用及新兴治疗策略,包括肽、寡聚物、抗体和疫苗
Int J Mol Sci. 2025 Jul 25;26(15):7198. doi: 10.3390/ijms26157198.
2
Receptor for Hyaluronan Mediated Motility (RHAMM)/Hyaluronan Axis in Breast Cancer Chemoresistance.乳腺癌化疗耐药中的透明质酸介导的运动受体(RHAMM)/透明质酸轴
Cancers (Basel). 2024 Oct 25;16(21):3600. doi: 10.3390/cancers16213600.
3
FOXM1 mediates methotrexate resistance in osteosarcoma cells by promoting autophagy.
FOXM1 通过促进自噬介导骨肉瘤细胞对甲氨蝶呤的耐药性。
Acta Biochim Biophys Sin (Shanghai). 2024 Jul 31;56(9):1289-1299. doi: 10.3724/abbs.2024084.
4
Hyaluronic Acid Interacting Molecules Mediated Crosstalk between Cancer Cells and Microenvironment from Primary Tumour to Distant Metastasis.透明质酸相互作用分子介导的癌细胞与从原发性肿瘤到远处转移的微环境之间的串扰
Cancers (Basel). 2024 May 16;16(10):1907. doi: 10.3390/cancers16101907.
5
LINC00665 promotes glycolysis in lung adenocarcinoma cells via the let-7c-5p/HMMR axis.LINC00665 通过 let-7c-5p/HMMR 轴促进肺腺癌细胞的糖酵解。
J Bioenerg Biomembr. 2024 Apr;56(2):181-191. doi: 10.1007/s10863-024-10004-3. Epub 2024 Feb 27.
6
Hyaluronic acid metabolism and chemotherapy resistance: recent advances and therapeutic potential.透明质酸代谢与化疗耐药:最新进展与治疗潜力。
Mol Oncol. 2024 Sep;18(9):2087-2106. doi: 10.1002/1878-0261.13551. Epub 2024 Mar 21.
7
RHAMM regulates MMTV-PyMT-induced lung metastasis by connecting STING-dependent DNA damage sensing to interferon/STAT1 pro-apoptosis signaling.RHAMM 通过将 STING 依赖性 DNA 损伤感应连接到干扰素/STAT1 促凋亡信号来调节 MMTV-PyMT 诱导的肺转移。
Breast Cancer Res. 2023 Jun 22;25(1):74. doi: 10.1186/s13058-023-01652-1.
8
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients.透明质酸介导运动受体 (RHAMM) 定义了与肿瘤进展相关的侵袭性生态位,并预测乳腺癌患者预后不良。
J Pathol. 2023 Jul;260(3):289-303. doi: 10.1002/path.6082. Epub 2023 Apr 26.
9
RHAMM marks proliferative subpopulation of human colorectal cancer stem cells.RHAMM 标记人类结直肠癌细胞的增殖亚群。
Cancer Sci. 2023 Jul;114(7):2895-2906. doi: 10.1111/cas.15795. Epub 2023 Mar 31.
10
Receptor for Hyaluronic Acid-mediated Motility (RHAMM) Is Associated With Prostate Cancer Migration and Poor Prognosis.透明质酸介导运动受体(RHAMM)与前列腺癌迁移和不良预后相关。
Cancer Genomics Proteomics. 2023 Mar-Apr;20(2):203-210. doi: 10.21873/cgp.20375.